Mayang Sari Ayu



Adherence patient in the treatment of second-line tuberculosis is the success of controlling drug resistant tuberculosis. Data from the World Health Organization report (2017) only about 66% of drug-resistant tuberculosis patients follow second-line treatment until recovery. WHO places Indonesia at level eight among countries with high burden with drug-resistant tuberculosis in the world. Objective: Analyze therapeutic service of adherence patient drug resistant tuberculosis treatment. Subjects and Methods: This type of research uses observational analytic cross sectional design, conducted at 3 microscopic referral community health centers in the city of Medan. The sample of the study consisted of 32 patients with total sampling technique. The independent variables were medical services, pharmaceutical services, and nursing services. The dependent variable is adherence patient drug resistant tuberculosis treatment. Sources of research data from primary data through structured interviews and secondary data from a review of the patient's medical record. Data analysis used chi square tests and multiple logistic regression tests with a confidence level of 95%. Results: The analysis shows that all variables have a significant relationship between therapeutic services and adherence patient with drug resistant tuberculosis treatment. Analysis of the variables of medical services (p=0.002), pharmaceutical services (p=0.020), and nursing services (p=0.003) affect the compliance of patients undergoing second-line tuberculosis treatment. Conclusion: Teraupetic service variable had a significant effect on adherence patient drug resistant tuberculosis treatment (p> 0.05). The therapeutic service effort at the community service center is providing easy access to services, overcoming side effects of treatment, active case treatment TB officers and family psychosocial support.

Keywords: Therapeutic Services, Drug-Resistant Tuberculosis, Medical Services, Pharmaceutical Services, Nursing Services

Full Text:




Akshata, J.S. and Chakrabarthy, A, 2016. Management of MDR-TB – Monitoring is the key to successful outcome. Egyptian Journal of Chest Diseases and Tuberculosis. 65:447–450.

CDC, 2017. National Action Plan For CombatingMultidrug-ResistantTubercolosis. Atlanta: The Centers for Disease Control and Prevention.

Falzon, D., Mirzayev, F., Wares, F., Baena, I.G., Zignol, M., Linh, N., et al. 2015. Multidrug-resistant tuberculosis around the world: what progress has been made?. Eur Respir J. 45: 150–160.

Kementerian Kesehatan RI, 2010. Farmaceutical Care Untuk Penyakit Tuberkulosis. Direktorat Bina Kefarmasian Komunitas dan Klinik serta Alat Kesehatan Departemen Kesehatan.

Kementerian Kesehatan Republik Indonesia Peraturan Menteri Kesehatan RI no 13. 2013. Pedoman Manajemen Terpadu Pengendalian Tuberkulosis Resistan Obat. Jakarta

Kementerian Kesehatan RI, 2015. Kebijakan Program Indonesia Sehat dengan Pendekatan Keluarga.

Kementerian Kesehatan RI, 2016. Pedoman Nasional Penanggulangan Tuberkulosis. Cetakan ke 8. Jakarta, Sistem Kesehatan Nasional. bab 10 hal. 70-73

Munir, M.S., Nawas, A. and Soetoyo, D.K., 2008. Pengamatan pasien tuberkulosis paru dengan multidrug resistant (TB-MDR) di Poliklinik Paru RSUP Persahabatan.

Profil Kesehatan Provinsi Sumatera Utara Tahun 2017. Medan: Dinas Kesehatan Provinsi Sumatera Utara.

Sastroasmoro, S., Madiyono, B., Moeslichan, S., Budiman, I. and Purwanto, S.H., 2002. Dasar-dasar metodologi penelitian klinis. Jakarta: Sagung Seto.

Tirtana, B. T., & Musrichan, M. 2011. Faktor-faktor yang mempengaruhi keberhasilan pengobatan pada pasien tuberkulosis paru dengan resistensi obat tuberkulosis di Wilayah Jawa Tengah (Doctoral dissertation, Faculty of Medicine).

Vause, A. and Aspinall, C. 2015. ‘Whole person’ approach used in complex TB case. A multidisciplinary health team successfully managed the complex care of a patient with drug-resistant tuberculosis, and other sig-nificant physical and mental problems. Kai Tiaki Nursing New Zealand. 21(8):30-31.

WHO, 2016. Companion Handbook for Programmatic Management of Drugs Resistant Tuberkulosis, Geneva:

WHO, 2017. TB Global Tuberculosis Report 2017, Multidrug and Extensively Drug Resistant- TB :

Zuliana I, 2009. Pengaruh Karakteristik Individu, Faktor Pelayanan Kesehatan dan Faktor Pengawas Menelan Obat Terhadap Tingkat Kepatuhan Penderita TB Paru Dalam Pengobatan di Puskesmas Pekan Labuhan Kota Medan Tahun 2009. FKM USU. Medan.



  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.